Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bintrafusp alfa and docetaxel in advanced NSCLC
NCT04396535Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Oct 2020
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
A Phase 2 trial of bintrafusp alfa in non-small cell lung cancer (NSCLC), sponsored by Mayo Clinic. Started Oct 2020; status: terminated.
02
Drugs
bintrafusp alfa
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04396535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04396535.